Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis
Few patients with LAM NSCLC in France received ICI retreatment following index nivolumab discontinuation, but the proportion increased with a longer duration of index nivolumab.
Authors
- Clarisse Audigier-Valette (ORCID: https://orcid.org/0000-0002-9518-9162)
- Minouk J. Schoemaker (ORCID: https://orcid.org/0000-0001-8403-2234)
- C. Rault (ORCID: https://orcid.org/0000-0001-9719-0653)
- C. Chouaïd (ORCID: https://orcid.org/0000-0002-4290-5524)
- D. Debieuvre (ORCID: https://orcid.org/0000-0002-8016-7956)
- Xavier Quantin (ORCID: https://orcid.org/0000-0002-5403-3612)
- H. Léna
- Bruno E. Correia (ORCID: https://orcid.org/0000-0002-7377-8636)
- M. Daumont (ORCID: https://orcid.org/0000-0002-4319-1498)
- G. Justeau (ORCID: https://orcid.org/0000-0002-2137-113X)
- L. Bosquet (ORCID: https://orcid.org/0000-0001-5100-9425)
- Marta Mella
- Nicolas M Girard (ORCID: https://orcid.org/0000-0001-9909-2299)
- Adam Lee (ORCID: https://orcid.org/0000-0001-8834-1296)
- John R. Penrod
- Maurice Pérol
Institutions
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université de Montpellier (FR)
- Université Paris-Saclay (FR)
- Bristol-Myers Squibb (United States) (US)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Bristol-Myers Squibb (United Kingdom) (GB)
- Bristol-Myers Squibb (Belgium) (BE)
- UniCancer Group (FR)
- Groupe Hospitalier de la Région de Mulhouse et Sud Alsace (FR)
- Hôpital Intercommunal de Créteil (FR)
- Université d'Angers (FR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3389/fonc.2025.1526931
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Bristol-Myers Squibb
- Unicancer